ATS 2020 Advance Program

extracorporeal life support. Patient care, result trial results and future uses of ECMO with management pearls will be presented. Objectives At the conclusion of this session, the participant will be able to: • interpret recent clinical trials related to ECMO and how they may affect future care; • understand what patient populations may best benefit from ECMO and when is optimal for initiation; • have improved understanding of how future extracorporeal techniques may be used in new populations of patients. The presentations will review results of recent ECMO trials and how they apply to clinical practice from international experts, future plans for ECMO and how they may benefit patient care, expansion of ECMO techniques to the home environment, in conditions of resuscitation or suspended animation will be provided. A panel discussion of difficult patient management scenarios will also be provided. Audience participation is also sought to ask questions. A rapid fire review of past and future ECMO highlights will be provided. Data provided will be applicable to adults and pediatric patients (although little neonatal content is included). Chairing: H.J. Dalton, MD, Falls Church, VA J.H. Badulak, MD, Seattle, WA 1:00 Late-Breaking New ECMO Study Results A. Combes, MD, PhD, Paris, France 1:20 The Science Behind Anticoagulation and ECMO: What's New and Why it Matters M.E. Steiner, MD, Minneapolis, MN 1:40 The Next Ten Years I.M. Cheifetz, MD, Durham, NC 2:00 How to Ventilate Before and During ECMO Speaker To Be Announced 2:20 Panel Discussion 2:40 My Top 10 Things to Know in 10 Minutes! J.H. Badulak, MD, Seattle, WA 2:50 My Top 10 Things to Know in 10 Minutes! H.J. Dalton, MD, Falls Church, VA ATS 2020 • Philadelphia, PA WEDNESDAY • MAY 20 147 1:00 p.m. - 3:00 p.m. Oral And Poster Presentations Of Scientific Research And Case Reports. Abstract Sessions Will Be Published In The Final Program.

RkJQdWJsaXNoZXIy MTM1ODMw